Published in:
Open Access
01-12-2019 | Stroke | Letter
Hypothermia after decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke: comment on the randomized clinical trial
Authors:
N. Engrand, M. Mazighi, V. Dinkelacker
Published in:
Critical Care
|
Issue 1/2019
Login to get access
Excerpt
Therapeutic hypothermia (TH) is currently evaluated in acute brain injury of diverse etiologies. In the clinical trial DEPTH-SOS, Neugebauer et al. [
1] reported negative results for TH (33 ± 1 °C) in malignant acute ischemic stroke (AIS) in adjunction to decompressive hemicraniectomy. TH improved neither survival at day 14 or at 12 months, nor long-term functional outcome. Instead, severe adverse events (SAE) in the TH-group entailed premature trial discontinuation. We revisit the study design with regard to its clinical objectives. …